SCHEMBL18362136

SCHEMBL18362136

CCC(=O)NCCn1cnnn1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
TP53 P04637 5/20 0.47
MAPT P10636 2/20 0.45
RAB9A P51151 2/20 0.44
THRB P10828 2/20 0.44
LMNA P02545 2/20 0.44
GAA P10253 1/20 0.42
MAPK1 P28482 1/20 0.42
POLB P06746 1/20 0.41
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
NPC1 O15118 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23028734 0.85 ALDH1A1 (0.48) ALDH1A1MEN1KMT2ATP53MAPT
SCHEMBL18072327 0.84 ALDH1A1 (0.52) ALDH1A1MEN1KMT2ATP53MAPT
SCHEMBL2848314 0.82 ALDH1A1 (0.54) ALDH1A1MEN1KMT2ATP53MAPT
SCHEMBL23028737 0.82 ALDH1A1 (0.46) ALDH1A1MEN1KMT2ATP53MAPT
SCHEMBL19755642 0.81 ALDH1A1 (0.48) ALDH1A1MEN1KMT2ATP53MAPT
SCHEMBL22282219 0.81 ALDH1A1 (0.48) ALDH1A1MEN1KMT2ATP53MAPT
SCHEMBL18072243 0.81 ALDH1A1 (0.52) ALDH1A1MEN1KMT2ATP53MAPT
SCHEMBL23028603 0.79 ALDH1A1 (0.42) ALDH1A1MEN1KMT2ATP53MAPT
SCHEMBL23028604 0.77 TP53 (0.43) ALDH1A1MEN1KMT2ATP53MAPT
SCHEMBL22281721 0.76 TP53 (0.43) ALDH1A1MEN1KMT2ATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11072585-B2 Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof PHARMAKEA, INC. (US) 2021-07-27 US disclosed
US-20200115341-A1 FLUORINATED LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF PHARMAKEA, INC. 2020-04-16 US disclosed
WO-2017003862-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF PHARMAKEA, INC. (US) 2017-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200115341-A1 FLUORINATED LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF LOXL2, LOXL1, LOX ALDH1A1 1095/4885MEN1 4032/4885KMT2A 963/4885
US-11072585-B2 Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof LOXL2, LOXL1, LOX ALDH1A1 1095/4885MEN1 4032/4885KMT2A 963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.